Extended ganciclovir prophylaxis in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 5, 2005, Pages 583-587

  Perreas, K G ^a,b   McNeil, K ^a   Charman, S ^a   Sharples, L D ^a   Wreghitt, T ^a   Wallwork, J ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DATA BASE; FEMALE; HLA TYPING; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; BRONCHIOLITIS OBLITERANS; CHEMOPREVENTION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 18844379707     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.02.005     Document Type: Article

References (12)

1. International Society for Heart and Lung Transplantation A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts J Heart Lung Transplant 12 1993 713 716
2. K. Bando, I.L. Paradis, H. Konishi Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation J Thorac Cardiovasc Surg 109 1995 49 59
3. D. Heng, L.D. Sharples, K. McNeil, S. Stewart, T. Wreghitt, J. Wallwork Bronchiolitis obliterans syndrome incidence, natural history, prognosis and risk factors J Heart Lung Transplant 17 1998 1255 1263
4. W.G. Nichols, M. Boeckh Recent advances in the therapy and prevention of CMV infections J Clin Virol 16 2000 25 40
5. M.V. Soghikian, V.G. Valentine, G.J. Berry, H.R. Patel, R.C. Robbins, J. Theodore Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients J Heart Lung Transplant 15 1996 881 887
6. F.K. Gould, R. Freeman, C.E. Taylor, T. Ashcroft, J.H. Dark, P.A. Corris Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation a review of experience in one center J Heart Lung Transplant 12 1993 695 699
7. R. Speich, R. Thurnheer, A. Gaspert, W. Weder, A. Boehler Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation Transplantation 67 1999 315 320
8. G.M. Mullen, M.A. Silver, K. Malinowska Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients Transplant Proc 30 1998 4110 4112
9. P.L. Hibberd, N.E. Tolkoff-Rubin, D. Conti Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients Ann Intern Med 123 1995 18 26
10. E.P. Trulock, L.B. Edwards, D.O. Taylor The Registry of the International Society for Heart and Lung Transplantation twentieth official adult lung and Heart-Lung transplant report-2003 J Heart Lung Transplant 22 2003 625 635
11. J.D. Cooper, G.A. Patterson, E.P. Trulock Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group J Thorac Cardiovasc Surg 107 1994 460 470
12. J.W. van den Berg, B.G. Hepkema, A. Geertsma Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches Transplantation 71 2001 368 373